<?xml version="1.0" encoding="UTF-8"?>
<p id="p0170">Health economics demonstrate an underuse of vaccines, partly due to the low understanding of the total value for money by vaccination when not only health parameters counts but also the economic benefits in society. Vaccination is among the most important public health innovations of all time and saves 6 million lives each year, including those of 2.5 million children [
 <xref rid="bib6" ref-type="bibr">6</xref>]. However, in Europe less than 0.5% of the Gross Domestic Product (GDP) is devoted to prevention and less than 0.5% of health expenditure (or 0.05% of GDP) is devoted to vaccination [
 <xref rid="bib7" ref-type="bibr">7</xref>]. The growing awareness of socio-economic benefits of vaccination demonstrates benefits achieved in education [
 <xref rid="bib8" ref-type="bibr">8</xref>], productivity [
 <xref rid="bib9" ref-type="bibr">9</xref>], poverty reduction [
 <xref rid="bib10" ref-type="bibr">10</xref>], fiscal [
 <xref rid="bib11" ref-type="bibr">11</xref>], and macroeconomic impact; the latter demonstrated in the ongoing COVID-19 pandemic. A better appreciation of the full socio-economic benefits of vaccination, in which return on investment from investing public funds in healthcare is about 300%, should lead to greater spending, innovation, and access.
</p>
